Braeckman Johan, Denis Louis
Department of Urology, UZ Brussel, Brussels, Belgium.
Oncology Center Antwerp (OCA), Antwerp, Belgium.
Asian J Urol. 2017 Jul;4(3):138-147. doi: 10.1016/j.ajur.2017.02.002. Epub 2017 Mar 30.
The diagnosis and treatment of benign prostatic obstruction (BPO) is based on a number of well-known lower urinary tract symptoms (LUTS) feared by all ageing males with functional testes. The ascent of modern urology turned this disease from lethal into an annoying but treatable health problem in the previous century. We are able to relieve the great majority of patients from their bothersome symptoms to a respectable quality of life by medication or removal of the obstructive part of the enlarged prostate. We can be proud of some progress made in the new millennium to reach a correct diagnosis and subsequent choice of treatment aiming for quality of life and cost-efficiency for public health. Still it remains symptomatic treatment and we expect the new generation of urologists to close some gaps in our knowledge on the regulation of prostatic growth to focus on prevention and elimination of the disease in the foreseeable future.
良性前列腺梗阻（BPO）的诊断和治疗基于一些所有睾丸功能正常的老年男性都惧怕的、广为人知的下尿路症状（LUTS）。在上个世纪，现代泌尿外科学的兴起将这种疾病从致命疾病转变为一种令人烦恼但可治疗的健康问题。通过药物治疗或切除前列腺增生的梗阻部分，我们能够使绝大多数患者摆脱令人烦恼的症状，过上质量尚可的生活。我们可以为新千年在实现正确诊断以及随后针对生活质量和公共卫生成本效益进行治疗选择方面所取得的一些进展感到自豪。然而，这仍然是对症治疗，我们期望新一代泌尿外科医生填补我们在前列腺生长调节知识方面的一些空白，以便在可预见的未来专注于预防和消除这种疾病。
